fda label pramlintide type 1 diabetes label adverse reactions Adverse events 28 Feb 2026—When used together with insulin,pramlintidemay cause hypoglycemia (low blood sugar), especially in patients withtype 1 diabetes. Low
Type 1 Diabetes SYMLIN is used with insulin and has been associated with an increased risk of insulin- induced severe hypoglycemia, particularly in patients withtype 1
Products
labels by G Ryan·2009·Cited by 124—Nausea was the most commonly reported adverse event. Pramlintide is an amylin analog that was FDA approved for the treatment of type 1 and type 2 diabetes.
Why Choose Us
We provide structured product coverage, market-focused resources, and practical selections aligned with evolving demand.
Our platform combines product visibility, business knowledge, and related topic clustering for stronger discovery.
From featured products to supporting articles, every section is designed to improve understanding and exploration.
Latest Insights
Here are the most common questions about fda label pramlintide type 1 diabetes label adverse reactions.